CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. · Healthcare · Market cap $3.5M
Insiders bought $4K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 19, 2026
Insider Buying
$16K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 19, 2026
CTT PHARMACEUTICAL HOLDINGS, INC.
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) has 19 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 19, 2026.
Inside the rolling window, 1 insider at CTT PHARMACEUTICAL HOLDINGS, INC. reported 17 open-market purchases totaling $16K and no open-market sales. The most active filer is CEO CTT PHARMACEUTICAL HOLDINGS, INC. with 17 filings. The most recent open-market filing is a purchase of 2,000 shares by CEO CTT PHARMACEUTICAL HOLDINGS, INC., dated Oct 15, 2026, worth $114.
- Industry:Medical - Pharmaceuticals
- CEO:Ryan Khouri
- Employees:1
- HQ:Tampa, FL, US
- IPO:1997-04-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CEO | Purchase | 2,000 | $114 | Oct 19 | +0.0% | SEC ↗ | |
| CEO | Purchase | 3,700 | $204 | Oct 6 | +4.1% | SEC ↗ | |
| CEO | Purchase | 10,100 | $455 | Sep 29 | +3.5% | SEC ↗ | |
| CEO | Purchase | 3,400 | $187 | Sep 28 | +3.5% | SEC ↗ | |
| CEO | Purchase | 10,900 | $523 | Sep 16 | +23.0% | SEC ↗ | |
| CEO | Purchase | 3,500 | $175 | Sep 10 | +13.7% | SEC ↗ | |
| CEO | Purchase | 9,800 | $479 | Sep 4 | +21.5% | SEC ↗ | |
| CEO | Purchase | 3,000 | $147 | Sep 2 | +20.5% | SEC ↗ | |
| CEO | Purchase | 3,500 | $172 | Aug 31 | +20.8% | SEC ↗ | |
| CEO | Purchase | 2,100 | $116 | Aug 25 | — | SEC ↗ | |
| CEO | Purchase | 11,500 | $518 | Aug 20 | — | SEC ↗ | |
| CEO | Purchase | 10,000 | $590 | Aug 19 | — | SEC ↗ | |
| CEO | Purchase | 1,800 | $112 | Aug 14 | — | SEC ↗ | |
CTT PHARMACEUTICAL HOLDINGS, INC.First in 8 months | CEO | Purchase | 7,700 | $501 | Aug 10 | — | SEC ↗ |
| CEO | Purchase | 8,300 | $457 | Dec 17 | — | SEC ↗ | |
| Director | Purchase | 262,900 | $11K | Nov 24 | — | SEC ↗ | |
CTT PHARMACEUTICAL HOLDINGS, INC.First filing | CEO | Purchase | 7,000 | $420 | Oct 31 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does CTTH have?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) has 19 SEC Form 4 filings (19 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 19, 2026.
When was the most recent SEC Form 4 filing for CTTH?
The most recent Form 4 filing for CTTH on Tracefour is dated Oct 19, 2026.
Who is the most active insider at CTTH?
The most active SEC Form 4 filer at CTTH in the rolling window is CEO CTT PHARMACEUTICAL HOLDINGS, INC., with 17 filings.
What is the net insider flow at CTTH over the last 6 months?
Over the trailing 180 days, insiders at CTTH have net bought $4K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CTTH in the current window?
Inside the rolling window, insiders at CTTH bought $16K and sold $0 based on SEC Form 4 filings.
Can I get alerts for CTTH insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CTT PHARMACEUTICAL HOLDINGS, INC. is in the Healthcare sector.